Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.
Curr Hematol Malig Rep. 2021 Feb;16(1):8-18. doi: 10.1007/s11899-021-00605-9. Epub 2021 Jan 28.
Curr Hematol Malig Rep. 2021.
PMID: 33507515
Review.
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies.
Danilov AV, Persky DO.
Danilov AV, et al.
Br J Haematol. 2021 Apr;193(1):15-25. doi: 10.1111/bjh.17184. Epub 2020 Nov 20.
Br J Haematol. 2021.
PMID: 33216986
Free article.
Review.
Item in Clipboard
Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials.
Gordon MJ, Huang J, Chan RJ, Bhargava P, Danilov AV.
Gordon MJ, et al.
Br J Haematol. 2021 Feb;192(4):720-728. doi: 10.1111/bjh.16879. Epub 2020 Jun 29.
Br J Haematol. 2021.
PMID: 32599655
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite